Search

Your search keyword '"Fanger, Gary R"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Fanger, Gary R" Remove constraint Author: "Fanger, Gary R"
128 results on '"Fanger, Gary R"'

Search Results

2. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy.

7. Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study

10. List of Contributors

11. Episensitization

20. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases

29. MEK kinase 1 gene disruption alters cell migration and c-Jun [NH.sub.2]-terminal kinase regulation but does not cause a measurable defect in NF-[Kappa]B activation

31. Abstract A1-35: RRx-001, a novel first in class epigenetic modulator, “episensitizes” colorectal patients to FOLFIRI: Preliminary resensitization data from the Phase 2 “ROCKET” study

36. Characterization of a Proapoptotic Antiganglioside GM2 Monoclonal Antibody and Evaluation of Its Therapeutic Effect on Melanoma and Small Cell Lung Carcinoma Xenografts

38. VSGP/F-Spondin: A New Ovarian Cancer Marker

41. P504S/α-Methylacyl-CoA Racemase

43. Detection of Mammaglobin in the Sera of Patients with Breast Cancer

44. P504S

45. MEK kinase 1 gene disruption alters cell migration and c-Jun NH 2 -terminal kinase regulation but does not cause a measurable defect in NF-κB activation

Catalog

Books, media, physical & digital resources